{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:34:14Z","timestamp":1740126854840,"version":"3.37.3"},"reference-count":18,"publisher":"Georg Thieme Verlag KG","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Introduction Polypoidal choroidal vasculopathy (PCV) is a vascular disease of the choroid. Diagnosis is mainly based on polypoidal aneurysm-like lesions seen in indocyanine green (ICG) angiography. Various therapeutic options have been proposed.<\/jats:p><jats:p>\n          Methods Outcomes of 10 cases with extrafoveal PCV and consecutive macular edema treated with thermal laser are reported. Diagnosis of PCV was confirmed by ICG angiography.<\/jats:p><jats:p>\n          Results Upon successful occlusion of the polyps in 10 eyes after thermal laser treatment demonstrated in ICG angiography, a regression of central foveal edema was seen in optical coherence tomography and color fundus photography. Visual acuity improved from logMAR 0.8 to logMAR 0.3. Follow-up ranged from 4 months to 15 years, with a median of 1 year. Two eyes had a recurrence of exudative maculopathy 5 and 7\u00a0years after laser treatment, respectively.<\/jats:p><jats:p>\n          Conclusion A careful differentiation between various subforms of exudative maculopathy using fluorescein and ICG angiography can identify certain selected patients with extrafoveal PCV, for whom thermal laser monotherapy can be a therapeutic option.<\/jats:p>","DOI":"10.1055\/a-1608-1946","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T22:44:22Z","timestamp":1632955462000},"page":"1299-1304","source":"Crossref","is-referenced-by-count":0,"title":["Thermal Laser Monotherapy for Extrafoveal Polypoidal Choroidal Vasculopathy"],"prefix":"10.1055","volume":"238","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9312-4085","authenticated-orcid":false,"given":"Viola Maria Margarete","family":"Radeck","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Augenheilkunde, Klinikum der Universit\u00e4t Regensburg, Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horst","family":"Helbig","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Augenheilkunde, Klinikum der Universit\u00e4t Regensburg, Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Valmaggia","sequence":"additional","affiliation":[{"name":"Augenklinik, Kantonsspital St.\u00a0Gallen, St.\u00a0Gallen, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5431-4991","authenticated-orcid":false,"given":"Daniel","family":"Barthelmes","sequence":"additional","affiliation":[{"name":"Ophthalmology, UniversitatsSpital Zurich Augenklinik und Poliklinik, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","article-title":"Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management","volume":"125","author":"C MG Cheung","year":"2018","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10792-020-01620-0","article-title":"Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices","volume":"41","author":"Y Sahu","year":"2021","journal-title":"Int Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00417-020-04940-0","article-title":"Pachychoroid: current concepts on clinical features and pathogenesis","volume":"259","author":"V Castro-Navarro","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s004170000180","article-title":"Polypoidal choroidal vasculopathy in Caucasians","volume":"238","author":"B A Lafaut","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-2005-858011","article-title":"Simultaneous fluorescein and indocyanine green angiography for exudative macular degeneration","volume":"222","author":"H Helbig","year":"2005","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317537","article-title":"Phenotypic and genetic variations between Asian and Caucasian polypoidal choroidal vasculopathy","author":"J M Jordan-Yu","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.survophthal.2010.03.004","article-title":"Polypoidal choroidal vasculopathy: a review","volume":"55","author":"Y Imamura","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000515295","article-title":"Polypoidal Choroidal Vasculopathy in Caucasians: Morphological Findings from Multimodal Retinal Imaging","volume":"244","author":"J M Sim\u00e3o","year":"2021","journal-title":"Ophthalmologica"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/sj.eye.6702955","article-title":"Argon laser photocoagulation for the treatment of polypoidal choroidal vasculopathy","volume":"23","author":"M W Lee","year":"2009","journal-title":"Eye (Lond)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/s0021-5155(03)00042-x","article-title":"A study of laser photocoagulation for polypoidal choroidal vasculopathy","volume":"47","author":"M Yuzawa","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ajo.2012.08.002","article-title":"Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy","volume":"155","author":"C M Gemmy Cheung","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1001\/archopht.1986.01050160059012","article-title":"Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Macular Photocoagulation Study Group","volume":"104","author":"Macular Photocoagulation Study Group","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1097\/IAE.0000000000000499","article-title":"Three-year results of polypoidal choroidal vasculopathy treated with photodynamic therapy: Retrospective Study and Systematic Review","volume":"35","author":"C W Wong","year":"2015","journal-title":"Retina"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.oret.2019.04.018","article-title":"Anti-Vascular Endothelial Growth Factor Resistance in Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy","volume":"3","author":"G T Kokame","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/bjophthalmol-2013-303444","article-title":"Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab response","volume":"98","author":"K Hatz","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy","volume":"32","author":"A Koh","year":"2012","journal-title":"Retina"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","article-title":"Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial","volume":"138","author":"T H Lim","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial","volume":"136","author":"W K Lee","year":"2018","journal-title":"JAMA Ophthalmol"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1608-1946.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:06:56Z","timestamp":1639008416000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1608-1946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":18,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,8]]},"published-print":{"date-parts":[[2021,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1608-1946","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"type":"print","value":"0023-2165"},{"type":"electronic","value":"1439-3999"}],"subject":[],"published":{"date-parts":[[2021,9,29]]}}}